Zobrazeno 1 - 10 of 277 pro vyhledávání: '"Lefresne S"'
1
Akademický článek
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the Population-Based SABR-5 Phase II Trial
Autor: Cruz-Lim, E.M. ∗, †, Mou, B. ∗, †, Jiang, W. ∗, ‡, Liu, M. ∗, §, Bergman, A. ∗, §, Schellenberg, D. ∗, ‡, Alexander, A. ∗, ¶, Berrang, T. ∗, ¶, Bang, A. ∗, §, Chng, N. ||, Matthews, Q. ||, Carolan, H. ∗, §, Hsu, F. ∗, ∗∗, Miller, S. ∗, ||, Atrchian, S. ∗, †, Chan, E. ∗, §, Ho, C. ∗, ‡, Mohamed, I. ∗, †, Lin, A. ∗, †, Huang, V. ‡, Mestrovic, A. §, Hyde, D. ∗, †, Lund, C. ∗, ‡, Pai, H. ∗, ¶, Valev, B. ∗, ¶, Lefresne, S. ∗, §, Tyldesley, S. ∗, §, Olson, R. ∗, ||, Baker, S. ∗, ‡
Publikováno v: In Clinical Oncology March 2024 36(3):141-147
Zobrazit plný text záznamu
2
Akademický článek
Prospective Longitudinal Assessment of Quality of Life After Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial
Autor: Cruz-Lim, E.M. ∗, †, Mou, B. ∗, †, Baker, S. ∗, ‡, Arbour, G. ∗, Stefanyk, K. ∗, Jiang, W. ∗, ‡, Liu, M. ∗, §, Bergman, A. ∗, §, Schellenberg, D. ∗, ‡, Alexander, A. ∗, ¶, Berrang, T. ∗, ¶, Bang, A. ∗, §, Chng, N. ||, Matthews, Q. ||, Carolan, H. ∗, §, Hsu, F. ∗, ∗∗, Miller, S. ∗, ||, Atrchian, S. ∗, †, Chan, E. ∗, †, Ho, C. ∗, ‡, Mohamed, I. ∗, †, Lin, A. ∗, †, Huang, V. ‡, Mestrovic, A. §, Hyde, D. ∗, †, Lund, C. ∗, ‡, Pai, H. ∗, ¶, Valev, B. ∗, ¶, Lefresne, S. ∗, §, Tyldesley, S. ∗, §, Olson, R. ∗, ||
Publikováno v: In Clinical Oncology March 2024 36(3):148-156
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
Autor: Schellenberg D; Department of Radiation Oncology, BC Cancer - Surrey, Surrey, British Columbia, Canada. Electronic address: dschellenberg@bccancer.bc.ca., Gabos Z; University of Alberta, Edmonton, Alberta, Canada., Duimering A; University of Alberta, Edmonton, Alberta, Canada., Debenham B; University of Alberta, Edmonton, Alberta, Canada., Fairchild A; University of Alberta, Edmonton, Alberta, Canada., Huang F; University of Alberta, Edmonton, Alberta, Canada., Rowe LS; University of Alberta, Edmonton, Alberta, Canada., Severin D; University of Alberta, Edmonton, Alberta, Canada., Giuliani ME; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Bezjak A; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Lok BH; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Raman S; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Chung P; Department of Radiation Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Zhao Y; Department of Radiation Oncology, BC Cancer - Surrey, Surrey, British Columbia, Canada., Ho CK; Department of Radiation Oncology, BC Cancer - Surrey, Surrey, British Columbia, Canada., Lock M; Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada., Louie AV; Department of Radiation Oncology, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Lefresne S; Department of Radiation Oncology, BC Cancer - Vancouver Centre, Vancouver, British Columbia, Canada., Carolan H; Department of Radiation Oncology, BC Cancer - Vancouver Centre, Vancouver, British Columbia, Canada., Liu M; Department of Radiation Oncology, BC Cancer - Vancouver Centre, Vancouver, British Columbia, Canada., Yau V; Department of Radiation Oncology, BC Cancer - Centre for the North, Prince George, British Columbia, Canada., Ye A; Department of Radiation Oncology, BC Cancer - Centre for the North, Prince George, British Columbia, Canada., Olson RA; Department of Radiation Oncology, BC Cancer - Centre for the North, Prince George, British Columbia, Canada., Mou B; Department of Radiation Oncology, BC Cancer - Kelowna, Kelowna, British Columbia, Canada., Mohamed IG; Department of Radiation Oncology, BC Cancer - Kelowna, Kelowna, British Columbia, Canada., Petrik DW; Department of Radiation Oncology, BC Cancer - Kelowna, Kelowna, British Columbia, Canada., Dosani M; Department of Radiation Oncology, BC Cancer - Victoria, Victoria, British Columbia, Canada., Pai H; Department of Radiation Oncology, BC Cancer - Victoria, Victoria, British Columbia, Canada., Valev B; Department of Radiation Oncology, BC Cancer - Victoria, Victoria, British Columbia, Canada., Gaede S; Department of Medical Physics, Western University, London, Ontario, Canada., Warner A; Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada., Palma DA; Department of Radiation Oncology, London Health Sciences Centre, London, Ontario, Canada.
Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Aug 19. Date of Electronic Publication: 2024 Aug 19.
Zobrazit plný text záznamu
5
Akademický článek
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET Collaboration.
Autor: Robledo KP; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia kristy.robledo@sydney.edu.au., Lefresne S; BC Cancer Agency, Vancouver, British Columbia, Canada.; The University of British Columbia, Vancouver, British Columbia, Canada., Soon YY; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.; National University Cancer Institute, Singapore.; National University Health System, Singapore., Sahgal A; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Pinkham MB; Radiation Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Nichol A; BC Cancer Agency, Vancouver, British Columbia, Canada., Soo RA; National University Cancer Institute, Singapore.; National University Health System, Singapore., Parmar A; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Hegi-Johnson F; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Doherty M; St Vincent's University Hospital, Dublin, Dublin, Ireland., Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Shultz DB; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Tham IW; Mount Elizabeth Hospital, Singapore., Sacher AG; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Tey J; National University Cancer Institute, Singapore.; National University Health System, Singapore., Leong CN; National University Cancer Institute, Singapore.; National University Health System, Singapore., Koh WY; National University Cancer Institute, Singapore.; National University Health System, Singapore., Huang Y; National University Cancer Institute, Singapore.; National University Health System, Singapore., Ang YLE; National University Cancer Institute, Singapore.; National University Health System, Singapore., Low J; National University Cancer Institute, Singapore.; National University Health System, Singapore., Yong C; National University Health System, Singapore.; National University Hospital, Singapore., Lim MC; National University Health System, Singapore.; National University Hospital, Singapore., Tan AP; National University Health System, Singapore.; National University Hospital, Singapore., Lee CK; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia., Ho C; BC Cancer Agency, Vancouver, British Columbia, Canada.; The University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v: BMJ open [BMJ Open] 2024 Jul 05; Vol. 14 (7), pp. e078335. Date of Electronic Publication: 2024 Jul 05.
Zobrazit plný text záznamu
6
Akademický článek
Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.
Autor: Baker S; University of British Columbia; BC Cancer-Surrey, Department of Radiation Oncology, Surrey, BC, Canada. Electronic address: sarah.baker1@bccancer.bc.ca., Lechner L; University of British Columbia., Liu M; University of British Columbia; BC Cancer-Vancouver, Department of Radiation Oncology, Vancouver, BC, Canada., Chang JS; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Cruz-Lim EM; University of British Columbia; BC Cancer-Kelowna, Department of Radiation Oncology, Kelowna, BC, Canada., Mou B; University of British Columbia; BC Cancer-Kelowna, Department of Radiation Oncology, Kelowna, BC, Canada., Jiang W; University of British Columbia; BC Cancer-Surrey, Department of Radiation Oncology, Surrey, BC, Canada., Bergman A; University of British Columbia; BC Cancer-Vancouver, Department of Radiation Oncology, Vancouver, BC, Canada., Schellenberg D; University of British Columbia; BC Cancer-Surrey, Department of Radiation Oncology, Surrey, BC, Canada., Alexander A; University of British Columbia; BC Cancer-Victoria, Department of Radiation Oncology, Victoria, BC, Canada., Berrang T; University of British Columbia; BC Cancer-Victoria, Department of Radiation Oncology, Victoria, BC, Canada., Bang A; University of British Columbia; BC Cancer-Vancouver, Department of Radiation Oncology, Vancouver, BC, Canada., Chng N; University of British Columbia; BC Cancer-Prince George, Department of Radiation Oncology, Prince George, BC, Canada., Matthews Q; University of British Columbia; BC Cancer-Prince George, Department of Radiation Oncology, Prince George, BC, Canada., Carolan H; University of British Columbia; BC Cancer-Vancouver, Department of Radiation Oncology, Vancouver, BC, Canada., Hsu F; University of British Columbia; BC Cancer-Abbotsford, Department of Radiation Oncology, Abbotsford, BC, Canada., Miller S; University of British Columbia; BC Cancer-Prince George, Department of Radiation Oncology, Prince George, BC, Canada., Atrchian S; University of British Columbia; BC Cancer-Kelowna, Department of Radiation Oncology, Kelowna, BC, Canada., Chan E; University of British Columbia; BC Cancer-Vancouver, Department of Radiation Oncology, Vancouver, BC, Canada., Ho C; University of British Columbia; BC Cancer-Surrey, Department of Radiation Oncology, Surrey, BC, Canada., Mohamed I; University of British Columbia; BC Cancer-Kelowna, Department of Radiation Oncology, Kelowna, BC, Canada., Lin A; University of British Columbia; BC Cancer-Kelowna, Department of Radiation Oncology, Kelowna, BC, Canada., Huang V; University of British Columbia; BC Cancer-Surrey, Department of Radiation Oncology, Surrey, BC, Canada., Mestrovic A; BC Cancer-Victoria, Department of Radiation Oncology, Victoria, BC, Canada., Hyde D; University of British Columbia; BC Cancer-Kelowna, Department of Radiation Oncology, Kelowna, BC, Canada., Lund C; University of British Columbia; BC Cancer-Surrey, Department of Radiation Oncology, Surrey, BC, Canada., Pai H; University of British Columbia; BC Cancer-Victoria, Department of Radiation Oncology, Victoria, BC, Canada., Valev B; University of British Columbia; BC Cancer-Victoria, Department of Radiation Oncology, Victoria, BC, Canada., Lefresne S; University of British Columbia; BC Cancer-Vancouver, Department of Radiation Oncology, Vancouver, BC, Canada., Arbour G; University of British Columbia., Yu I; University of British Columbia; BC Cancer-Surrey, Department of Radiation Oncology, Surrey, BC, Canada., Tyldesley S; University of British Columbia; BC Cancer-Vancouver, Department of Radiation Oncology, Vancouver, BC, Canada., Olson RA; University of British Columbia; BC Cancer-Prince George, Department of Radiation Oncology, Prince George, BC, Canada.
Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Apr 01; Vol. 118 (5), pp. 1497-1506. Date of Electronic Publication: 2024 Jan 12.
Zobrazit plný text záznamu
7
Akademický článek
Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.
Autor: Olson R; University of British Columbia, Vancouver, Canada. rolson2@bccancer.bc.ca.; University of Northern British Columbia, Prince George, Canada. rolson2@bccancer.bc.ca.; BC Cancer - Prince George, 1215 Lethbridge Street, Prince George, BC, V2M7A9, Canada. rolson2@bccancer.bc.ca.; Department of Radiation Oncology, BC Cancer - Centre for the North, 1215 Lethbridge Street, Prince George, British Columbia, V2M 7E9, Canada. rolson2@bccancer.bc.ca., Abraham H; BC Cancer - Prince George, 1215 Lethbridge Street, Prince George, BC, V2M7A9, Canada., Leclerc C; University of British Columbia, Vancouver, Canada.; BC Cancer - Prince George, 1215 Lethbridge Street, Prince George, BC, V2M7A9, Canada., Benny A; University of British Columbia, Vancouver, Canada., Baker S; BC Cancer - Surrey, Surrey, British Columbia, Canada., Matthews Q; BC Cancer - Prince George, 1215 Lethbridge Street, Prince George, BC, V2M7A9, Canada., Chng N; BC Cancer - Prince George, 1215 Lethbridge Street, Prince George, BC, V2M7A9, Canada., Bergman A; BC Cancer - Vancouver, Vancouver, British Columbia, Canada., Mou B; BC Cancer - Kelowna, Kelowna, British Columbia, Canada., Dunne EM; BC Cancer - Vancouver, Vancouver, British Columbia, Canada., Schellenberg D; BC Cancer - Surrey, Surrey, British Columbia, Canada., Jiang W; BC Cancer - Surrey, Surrey, British Columbia, Canada., Chan E; BC Cancer - Vancouver, Vancouver, British Columbia, Canada., Atrchian S; BC Cancer - Kelowna, Kelowna, British Columbia, Canada., Lefresne S; BC Cancer - Vancouver, Vancouver, British Columbia, Canada., Carolan H; BC Cancer - Vancouver, Vancouver, British Columbia, Canada., Valev B; BC Cancer- Victoria, Victoria, British Columbia, Canada., Tyldesley S; BC Cancer - Vancouver, Vancouver, British Columbia, Canada., Bang A; BC Cancer - Vancouver, Vancouver, British Columbia, Canada., Berrang T; BC Cancer- Victoria, Victoria, British Columbia, Canada., Clark H; BC Cancer - Surrey, Surrey, British Columbia, Canada., Hsu F; BC Cancer- Abbotsford, Abbotsford, British Columbia, Canada., Louie AV; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Warner A; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada., Palma DA; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada., Howell D; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Barry A; Cork University Hospital, Cork, Ireland., Dawson L; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Grendarova P; BC Cancer- Victoria, Victoria, British Columbia, Canada., Walker D; Patient partner, BC Cancer-Prince George, Prince George, BC, Canada., Sinha R; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Tsai J; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Bahig H; Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada., Thibault I; Centre Hospitalier Universitaire de Québec (CHUQ), Québec, Canada., Koul R; Cancer Care Manitoba, Winnipeg, Manitoba, Canada., Senthi S; Alfred Health Radiation Oncology, Melbourne, Australia., Phillips I; Western General Hospital/Edinburgh Cancer Centre, Edinburgh, Scotland., Grose D; Beatson West of Scotland Cancer Centre, Glasgow, Scotland., Kelly P; Bon Secours Radiotherapy Cork (In Partnership with UPMC Hillman Cancer Centre), Cork, Ireland., Armstrong J; St. Luke's Radiation Oncology Network, Dublin, Ireland., McDermott R; University Hospital Galway, Galway, Ireland., Johnstone C; Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America., Vasan S; Precision Cancer Center, Ashland, Kentucky, United States of America., Aherne N; Riverina Cancer Care Centre, Wagga Wagga, New South Wales, Australia., Harrow S; Western General Hospital/Edinburgh Cancer Centre, Edinburgh, Scotland., Liu M; BC Cancer - Vancouver, Vancouver, British Columbia, Canada.
Publikováno v: BMC cancer [BMC Cancer] 2024 Feb 03; Vol. 24 (1), pp. 171. Date of Electronic Publication: 2024 Feb 03.
Zobrazit plný text záznamu
8
Akademický článek
Exploring the value of structured narrative feedback within the Serious Illness Conversation-Evaluation Exercise (SIC-Ex): a qualitative analysis.
Autor: Ko J; Department of Medical Oncology, BC Cancer Agency Abbostford Centre, Abbotsford, British Columbia, Canada Jenny.Ko@bccancer.bc.ca., Roze des Ordons A; Department of Critical Care Medicine and Division of Palliative Medicine; Department of Anesthesiology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada., Ballard M; Department of Internal Medicine, Chilliwack General Hospital, Chilliwack, British Columbia, Canada., Shenkier T; Department of Medical Oncology, BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada., Simon JE; Department of Oncology and Community Health Sciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada., Fyles G; Pain and Symptom Management/Palliative Care Program, BC Cancer Agency Sindi Ahluwalia Hawkins Centre for the Southern Interior, Kelowna, British Columbia, Canada., Lefresne S; Department of Radiation Oncology, BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada., Hawley P; Department of Palliative Care, BC Cancer Agency, Vancouver, British Columbia, Canada., Chen C; Department of Oncology and Community Health Sciences, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada., McKenzie M; Department of Radiation Oncology, BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada., Sanders J; Department of Palliative Care, McGill University, Montreal, Quebec, Canada., Bernacki R; Department of Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publikováno v: BMJ open [BMJ Open] 2024 Jan 29; Vol. 14 (1), pp. e078385. Date of Electronic Publication: 2024 Jan 29.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje